MedPath

Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab

Not Applicable
Completed
Conditions
Non-Hodgkin Lymphoma (NHL)
Registration Number
NCT01707628
Lead Sponsor
St. Antonius Hospital
Brief Summary

The purpose of this study is to compare the number of responders to vaccination with the influenza virus vaccine at different time points after last dose of rituximab in patients with lymphoma. Secondly to study the immune-response to vaccination with influenza virus vaccine, after treatment with rituximab in relation to the reconstitution of immune-function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  1. Patients with non-Hodgkin's lymphoma, treated with rituximab (with a range of 6-12 cycles) and who are in remission.
  2. Completion of rituximab therapy in the last twelve months before start of the study.
  3. Age ≥ 18 years.
  4. Signing of informed consent.
Exclusion Criteria
  1. Completion of rituximab therapy 7-8 months before start of the study.
  2. Fever at time of vaccination.
  3. Previous/known allergic reaction to any of the components of the vaccines given.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Influenza antibody titre3 weeks after vaccination
Secondary Outcome Measures
NameTimeMethod
immunoglobulin levels6 months
IgG subclasses6 months
production of IFN-γ by CD4+ cells6 months
Cytokines6 months
genetic factors6 months
lymphocyte subsets6 months
number of memory B cells6 months

Trial Locations

Locations (7)

Medisch Centrum Leeuwarden

🇳🇱

Leeuwarden, Friesland, Netherlands

Canisius Wilhelmina Hospital

🇳🇱

Nijmegen, Gelderland, Netherlands

Onze Lieve Vrouwen Gasthuis

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Medisch Spectrum Twente

🇳🇱

Enschede, Overrijssel, Netherlands

St. Antonius Hospital

🇳🇱

Nieuwegein, Utrecht, Netherlands

Reinier de Graaf Groep

🇳🇱

Delft, Zuid-Holland, Netherlands

Albert Schweitzer Hospital

🇳🇱

Dordrecht, Zuid-Holland, Netherlands

Medisch Centrum Leeuwarden
🇳🇱Leeuwarden, Friesland, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.